TerminatedPhase 3

Haloperidol, Droperidol, Ondansetron in Cannabis Hyperemesis

Stopped: Lost too many patients to follow up, unable to enroll enough patients

United States32 participantsStarted 2021-08-30

Plain-language summary

The purpose of this study is to compare two commonly used agents for the treatment of cyclic vomiting to see if one agent is inferior to the other in time to improvement in symptoms, need for repeat or rescue medications, treatment failures and complications/side effects.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * adult patients with clinical diagnosis of cyclic vomiting in the ED Exclusion Criteria: * pregnancy, allergy to any of the study medicines

What they're measuring

Abdominal Pain

Timeframe: 2 hours

Nausea

Timeframe: 2 hours

Abdominal Pain

Timeframe: 24 hours

Nausea

Timeframe: 24 hours

Abdominal Pain

Timeframe: 48 hours

Nausea

Timeframe: 48 hours

Trial details

NCT IDNCT05065567

SponsorCorewell Health South

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-11-20

Results submitted2024-12-02

View on ClinicalTrials.gov More Cyclic Vomiting Syndrome trials